ASH2020: The First-in-Class Anti-CD47 Antibody for AML
/ David A. Sallman
ASH2020: Recurrent Crebbp Mutations in Follicular Lymphoma
/ Joe Schroers-Martin
ASH2020: Promising results for treatment of AML
/ Tapan M. Kadia